Dr. Albitar on the Importance of Obtaining Genomic Testing in Oncology

Maher Albitar, MD, founder, chief executive office, chief medical officer, Genomic Testing Cooperative, discusses the importance of obtaining genomic testing in oncology.

Obtaining genomic information in oncology can inform a patient’s diagnosis, Albitar says. Moreover, genomic testing can help in understanding complicated disease presentations.

Additionally, genomic information can provide insight into a patient’s prognosis, treatment selection, long-term management strategies, minimal residual disease, comorbidity factors, and the risk of adverse effects of therapy, Albitar explains. Ultimately, obtaining genomic testing can help to guide providers and patients through common challenges encountered during the patient’s disease course and cancer treatment journey, Albitar concludes.